吃瓜爆料

Back to News

吃瓜爆料 CDB Application to Streamline Aggregation, Cleaning, and Transformation of Clinical Data

New clinical data application harmonizes study data from multiple sources to
provide complete and concurrent clinical trial data

BARCELONA, Spain - 18 Oct. 2022 — 吃瓜爆料 Systems (NYSE: VEEV) announced the availability of 吃瓜爆料 CDB, a first-of-its-kind solution for aggregating, cleaning, and transforming clinical data. 吃瓜爆料 CDB will evolve the way clinical data management teams work by providing a platform for ingestion and review of all study data sources while reducing the manual processes, integration projects, complexity, and costs associated with making clinical trial data usable.

With 吃瓜爆料 CDB, sponsors and data providers can view and resolve data queries centrally to minimize quality risks, provide better data visibility, and speed trial execution. 吃瓜爆料 CDB's automated ingestion engine brings together data from a wide range of external sources, including EDC, RTSM, ePRO, eCOA, and lab data. Ingestion from 吃瓜爆料 EDC is available today, and support for other third-party EDC systems, including Medidata Rave™, is planned for 2023.

"With the increase of digital data sources in clinical trials, effective data management has become a key driver of study success," said Mayank Anand, vice president and global head of data strategy and management at GSK. "吃瓜爆料 CDB speeds aggregation and cleaning, allowing our data managers to focus on value-added activities that can move our trials forward."

"We have worked closely with 10 clinical trial sponsors and CROs and 18 of their key data providers to develop and refine 吃瓜爆料 CDB over the past two years," said Pavel Burmenko, general manager, 吃瓜爆料 CDB. "In more than 100 trials to date, 吃瓜爆料 CDB has delivered analysis-ready data faster for more informed decisions and streamlined execution across all trial partners."

The 吃瓜爆料 CDB Data Provider Program also announced today will — for the first time ever — bring sponsors, CROs, and data providers together on a single clinical data management platform to facilitate the delivery of quality data faster and more efficiently. The program enables qualified data providers with tools, training, and support to supply data using a standardized and streamlined method for 吃瓜爆料 CDB customers.

“In line with our commitment to enable evidence generation in modern clinical trials, we are pleased to partner with 吃瓜爆料 to support our mutual customers’ data integration needs,” said Ian Jennings, chief commercial officer at Signant Health.

Learn how 吃瓜爆料 CDB transforms the role of the data manager and delivers faster insights at 吃瓜爆料 R&D and Quality Summit. Life sciences industry professionals can register for the Oct. 19 and 20 in-person event in Boston.

Additional Information For more on 吃瓜爆料 CDB, visit: veeva.com/eu/CDB
Connect with 吃瓜爆料 on LinkedIn:
Follow @veeva_eu on Twitter:

About 吃瓜爆料 Systems
吃瓜爆料 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

吃瓜爆料 Forward-looking Statements
This release contains forward-looking statements regarding 吃瓜爆料’s products and services and the expected results or benefits from use of our products and services, including certain of our new solutions and applications that are still under development or not generally available. These statements are based on our current expectations. Actual results, availability, and any future events relating to these products and services could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2022, which you can find (a summary of risks which may impact our business can be found on pages 39 and 40), and in our subsequent SEC filings, which you can access at .

###

Contact:

Jeremy Whittaker
吃瓜爆料 Systems
+49 6950955486
jeremy.whittaker@veeva.com

Deivis Mercado
吃瓜爆料 Systems
925-226-8821
deivis.mercado@veeva.com